logo

For the Inventor, By the Inventor

Boston, MA, United States of America

Scott A Armstrong

This inventor holds 9 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignees: Dana-Farber-Cancer Institute Inc., Memorial Sloan Kettering Cancer Center, Whitehead Institute for Biomedical Research. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott A Armstrong. Retrieved from https://idiyas.com/inventor/scott-a-armstrong-ulnr6gme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 66.7

 

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Boston, MA (US) (2017)
  • Wayland, MA (US) (2006 - 2022)
  • New York, NY (US) (2019 - 2023)
  • Mayland, MA (US) (2023)

Company Filing History:

goldMedal5 out of 1,268 
 
Dana-Farber-Cancer Institute Inc.
 patents
silverMedal4 out of 621 
 
Memorial Sloan Kettering Cancer Center
 patents
bronzeMedal1 out of 318 
 
Whitehead Institute for Biomedical Research
 patents
where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 12479852 - Compounds, compositions, and methods for protein degradation (2025-11-25),
2. 12331069 - DOT1L degraders and uses thereof (2025-06-17),
3. 11634450 - DOT1L degraders and uses thereof (2023-04-25),
4. 11603570 - Methods for the detection and treatment of leukemias that are responsive to DOT1L inhibition (2023-03-14),
5. 11248229 - Inhibition of KMT2D for the treatment of cancer (2022-02-15),
6. 10869868 - Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia (2020-12-22),
7. 10407732 - Methods for the detection and treatment of leukemias that are responsive to DOT1L inhibition (2019-09-10),
8. 9700565 - Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias (2017-07-11),
9. 7011947 - MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia (2006-03-14),

Title: Scott A Armstrong - Pioneering Inventor from Boston, MA

Introduction: Scott A Armstrong is a renowned inventor based in Boston, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Scott A Armstrong holds several patents in the areas of biotechnology, medical devices, and renewable energy, showcasing his diverse expertise and innovative mindset.

Career Highlights: With over two decades of experience in the industry, Scott A Armstrong has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized their respective fields.

Collaborations: Throughout his career, Scott A Armstrong has collaborated with top scientists, engineers, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Scott A Armstrong's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…